NCT02633761.

Trial name or title	Mifepristone and misoprostol versus misoprostol alone for treatment of fetal death at 14‐28 weeks of pregnancy: a randomised, placebo‐controlled double‐blinded trial
Methods	Allocation: randomised Intervention model: parallel assignment Masking: quadruple (participant, care provider, investigator, outcomes assessor) Primary purpose: treatment
Participants	Inclusion criteria Demised fetus of between 14 to 28 weeks duration confirmed by ultrasound Have no contraindications to study procedure, according to provider Be able to consent to procedure, either by reading consent document or by having consent document read to her Be willing to follow study procedures
Interventions	Active comparator group 1: 200 mg mifepristone followed in 24 hours by repeated doses of 200 μg: buccal misoprostol given every 3 hours Placebo comparator group 2: placebo followed in 24 hours by 200 μg: buccal misoprostol given every 3 hours.
Outcomes	Complete uterine evacuation of the fetus and placenta without surgical intervention [time frame: 48 hours] Complete uterine evacuation of fetus and placenta using study drug alone without recourse to any additional surgical intervention
Starting date	April 2015
Contact information	Hillary Bracken, PhD; hbracken@gynuity.org
Notes